HLA-C and neoplasm: According to the process of antigen recognition, immunogenomics technologies perform in silico analysis to predict abnormal peptides, perform HLA typing and predict MHC-peptide binding affinity, which is greatly helpful and necessary for the identification of tumor antigens (Table 1).